Tampa, Florida, United States – TheNewswire – November 20, 2025 - CTT Pharmaceutical Holdings, Inc.(OTCQB:CTTH) is pleased to announce that the CEO of CTT Pharma will issue a letter to shareholders on December 2, 2025. The letter will outline several initiatives underway that will advance CTT’s strategic direction, including updates on our S-1 filing, which will allow CTT to become a full SEC reporting company.  Thus allowing CTT access to funding from our equity line of credit, and help accelerate gro ...